Experimental Design: Southern blots were performed on three different varieties containing MON 810. Blots were hybridized with three different probes corresponding to the 35S promoter, the 3′ end of the cry1Ab coding sequence, and to the 3′ flank region. SNP analysis was performed on 28 different MON 810 varieties. Each variety was assayed in triplicate by PCR, followed CelI endonuclease digestion and subsequent analysis by capillary microelectrophoresis. Cytosine methylation was analyzed by bisulfite sequencing of genomic DNA extract from the V7 leaves of seven different MON 810 varieties. Symmetrical and asymmetrical cytosine methylation was examined in the 35S promoter, in the cry1Ab coding region, and in the 5′ flank region. The accumulation of cry1Ab mRNA was evaluated in two MON 810 varieties using a previously validated quantitative real-time PCR assay.
Results: Southern blot banding patterns were identical for each of the three varieties tested. No SNPs or indels (insertions or deletions) were found within the inserted DNA, and no SNPs or indels were found within 500 bases of the inserted DNA in either flank in the 28 MON 810 varieties that were tested. There was very little difference in cytosine methylation of the inserted DNA in leaves of different varieties and at different developmental stages. The level of cry1Ab mRNA accumulation is decreases over the course of leaf development.
The results indicate that the inserted DNA and the locus surrounding the inserted DNA in MON 810 is no less stable than endogenous maize genes. There was very little difference in cytosine methylation of the inserted DNA in leaves of different varieties and at different developmental stages. The authors noted that the level of cry1Ab mRNA accumulation decreases over the course of leaf development. They attribute this to a developmental and/or tissuespecific effect on the expression of the 35S promoter.
Environment
No adverse effects were detected in this study
Observed parameter
Feedback on initial environmental risk assessment:
Genetic stability
There are no changes to the conclusions of safety of the initial risk assessment
In the wet season the concentrations of Cry1Ab protein for whorl leaf averaged across the seven hybrids, ranged from 19.30-9.92 ppm at 15 DAE to 11.08 -4.66 ppm at 60 DAE. Similarly mean Cry1Ab concentration in the stem across seven hybrids ranged from 14.28-4.98 to 4.69-1.54 ppm between 15 and 60 DAE. A two-factorial (hybrids, sampling time points) ANOVA revealed no significant differences between the seven hybrids in Cry1Ab concentrations in whorl leaves or stem. However a two-factorial (hybrids, seasons) ANOVA between three common hybrids grown in wet and dry season for Cry1Ab contents in leaf revealed significant difference between the seasons at all sampling time points except at 90 DAE, indicating a possible seasonal preference of the three hybrids for leaf expression of Cry1Ab. But, the same three hybrids did not show a significant difference in stem concentrations of Cry1Ab between the two seasons. (Delgado and Wolt, 2010) Objective: To estimate the long-term exposure of fumonisin B 1 (FB 1 ) in nursery swine diets and associated toxicological adverse effects on negative productivity potential using quantitative exposure assessment (deterministic and stochastic modeling).
Experimental Design: Six different feeding scenarios differing in the source of maize (Bt-maize, non-Bt-maize and distillers dried grains with soluble -DDGS) in diets were modeled to assess variation in FB 1 exposure 1 . FB 1 concentrations in the different sources were determined by review of the literature.
Results: Diets where the maize fraction was entirely from Bt-maize showed the least FB 1 exposure (exceeding the first level of concern in 35% of occasions), whereas a blended diet or diets using non-Bt grain and DDGS sources more commonly exceeded this threshold (95% of occasions). Objective: To evaluate the effects of genetically modified maize on performance of lactating dairy cows over 25 months.
Experimental Design: Thirty-six dairy cows were assigned to two feeding groups and fed with diets based on whole-crop silage, kernels and whole-crop cobs from MON 810 or its isogenic not genetically modified counterpart (CON) as main components. The study included two consecutive lactations.
Results: There were no differences in the chemical composition and estimated net energy content of MON 810 and CON maize components and diets. CON feed samples were negative for the presence of Cry1Ab protein, while in MON 810 feed samples the Cry1Ab protein was detected. Cows fed MON 810 maize had a daily Cry1Ab protein intake of 6.0 mg in the first lactation and 6.1 mg in the second lactation of the trial. Dry matter intake (DMI) was 18.8 and 20.7 kg/cow per day in the first and the second lactation of the trial, with no treatment differences. Similarly, milk yield (23.8 and 29.0 kg/cow per day in the first and the second lactation of the trial) was not affected by dietary treatment. There were no consistent effects of feeding MON 810 or its isogenic CON on milk composition or body condition.
This long-term study demonstrated the compositional and nutritional equivalence of MON 810 maize and its isogenic control when fed to lactating cows for two consecutive lactations.
Animal health
Observed parameter
Animal performance
Review of Peer-Reviewed Publications -Food/Feed -Annual Report on the General Surveillance of MON 810 in the EU (Swiatkiewicz et al., 2011) Objective: To estimate the effect of feeding pigs with genetically modified soybean meal (SBM) and maize on fattening results and fate of transgenic DNA in pig tissues.
Experimental design:
The experiment was carried out on 48 fatteners divided in four groups receiving feed mixtures according to requirement of growing and finishing pigs. The feed mixtures were 1) control (non-GM) SBM and maize; 2) SBM from 40-3-2 and control maize; 3) maize from MON 810 and control SBM; and 4) SBM and maize from 40-3-2 and MON 810, respectively. The experiment lasted from about 30 kg to 110 kg of their body weigh. At the end of fattening, all pigs were slaughtered and right half of carcass was evaluated. Growth, carcass yields and meat composition were measured and digesta, organs and meat were sampled for detecting DNA 170 or 172 bp fragments by PCR for MON 810 or 40-3-2, respectively.
Results: Growth, carcass yields and carcass composition were unaffected by diets. DNA fragments were detected in digesta from the stomach and duodenum but not from other, lower gastrointestinal tract segments. Fragments were also not detected from organs or loin muscle. Histopathology of muscle and organs were unaffected by diets. Experimental design: Humoral and cellular specific immune responses induced in BALB/cJ mice after intra-gastric (i.g.) or intra-peritoneal (i.p.) administration of purified Cry1Ab were analyzed and compared with those induced by proteins of various immunogenic and allergic potencies. Cry1Ab protoxin was produced from the B. thuringiensis 407-strain harboring the pHT315Ωcry1Ab plasmid. Possible unintended effects of the genetic modification on the pattern of expression of maize natural allergens were studied using IgE-immunoblot and sera from maize-allergic patients. Mice were experimentally sensitized (i.g. or i.p. route) with protein extracts from GM or non-GM maize, and then anti-maize proteins and anti-Cry1Ab-induced immune responses were analyzed. In parallel, longitudinal metabolomic studies were performed on the urine of mice treated via the i.g. route.
Results: Weak immune responses were observed after i.g. administration of the different proteins. Using the i.p. route, a clear Th2 response was observed with the known allergenic proteins, whereas a mixed Th1/Th2 immune response was observed with immunogenic protein not known to be allergenic and with Cry1Ab. This then reflects protein immunogenicity in the BALB/c Th2-biased mouse strain rather than allergenicity. No difference in natural maize allergen profiles was evidenced between MON 810 and its non-GM comparator. Immune responses against maize proteins were quantitatively equivalent in mice treated with MON 810 vs. the non-GM counterpart and no anti-Cry1Ab-specific immune response was detected in mice that received MON 810. Metabolomic studies showed a slight "cultivar" effect, which represented less than 1% of the initial metabolic information. 
Observed parameter
Toxicology There are no changes to the conclusions of the safety of the initial risk assessment.
___________________________________________________________________________________________________________
Review of Peer-Reviewed Publications -Food/Feed -Annual Report on the General Surveillance of MON 810 in the EU
Publication

Summary of research and results
Conclusions
Protection goal Adverse effects (Randhawa et al., 2011) Objective: Evaluate the potential cross-reactivity of Cry proteins, including Cry1Ab, using bioinformatics search tools.
Experimental design:
The amino acid sequences of the Cry proteins, including Cry1Ab, were compared to all allergens in the AllergenOnline database using FASTA3 algorithm and NCBI Entrez database using BLASTX algorithm. Additionally, search for similarity in domains of the allergen and Cry proteins was conducted.
Results: No significant alignment or sequence similarity was observed between the Cry proteins and known allergens revealing there is no potential risk of allergenic cross-reactivity.
None of the proteins were found positive for potentially allergenic cross-reactivity. Hence, the criteria for potential cross-reactivity have not been reached. This demonstrates that any significant risk of crossreactivity for those who are allergic to known allergens is not expected.
Human health
Observed parameter
Feedback on initial environmental risk assessment: Objective: The objective of this study was to investigate the fate of transgenic cry1Ab DNA and the encoded Cry1Ab protein during the metabolic degradation of dietary feed components in dairy cows and a potential transfer to blood, milk, feces or urine.
Experimental Design: A 25-month long-term feeding trial was conducted on thirty-six Simmentaler cows allocated in two groups fed diets containing either genetically modified maize (MON 810, N=18) or the near-isogenic maize variety (N=18). The nutrients and energy contents of both maize varieties were comparable, ensuring equivalent feed conditions. Feed samples were collected weekly, whereas samples for feces, blood and milk were collected monthly, urine samples were taken bimonthly. All samples were analyzed for cry1Ab DNA by means of end-point PCR (feces, blood, urine) and quantitative real-time PCR (feed, milk). A sensitive and highly specific ELISA, optimized to quantify immunoreactive fragments of the Cry1Ab protein, was used to determine the recombinant protein in the collected samples.
The decision limit (CCα) and the decision capability (CCβ) of the ELISA were determined according to the guidelines of the European Commission Decision 202/657/EC.
Results: Non-transgenic feed samples were free of recombinant DNA and protein within the limit of detection, while in transgenic feed samples both, a 206 bp fragment of cry1Ab and immunoreactive fragments of the Cry1Ab protein were present. Cows fed Bt-MON 810 maize had a daily Cry1Ab protein intake of 6.0 mg in the first lactation and 6.1 mg in the second lactation of the trial. In contrast, all blood, milk and urine samples were free of recombinant DNA and protein. The cry1Ab gene was not detected in any fecal sample, whereas immunoreactive fragments of the Cry1Ab protein were detected in feces from all cows fed transgenic feed. Objective: To investigate the relative degradation and fragmentation pattern of the recombinant Cry1Ab protein from genetically modified (GM) maize MON 810 throughout the gastrointestinal tract (GIT) of dairy cows.
Experimental Design: A 25 months GM maize feeding study was conducted on 36 lactating Bavarian Fleckvieh cows allocated into two groups (18 cows per group) fed diets containing either MON 810 or nearly isogenic non-GM maize as the respective diet components. All cows were fed a partial total mixed ration (pTMR). During the feeding trial, 8 feed (4 transgenic (T) and 4 non-transgenic (NT) pTMR) and 42 feces (26 T and 18 NT) samples from the subset of cows fed T and NT diets, and at the end of the feeding trial, digesta contents of rumen, abomasum, small intestine, large intestine and cecum were collected after the slaughter of six cows of each feeding group. Samples were analyzed for Cry1Ab protein and total protein using Cry1Ab specific ELISA and bicinchoninic acid assay, respectively. Immunoblot analyses were performed to evaluate the integrity of Cry1Ab protein in feed, digesta and feces samples.
Results:
A decrease to 44% in Cry1Ab protein concentration from T pTMR to the voided feces (9.40 versus 4.18 ug/g of total proteins) was recorded.
Concentrations of Cry1Ab protein in GIT digesta of cows fed T diets varied between the lowest 0.38 ug/g of total proteins in abomasum to the highest 3.84 ug/g of total proteins in rumen. Immunoblot analysis revealed the extensive degradation of recombinant Cry1Ab protein into a smaller fragment of around 34 kDa in GIT. (Swiatkiewicz et al., 2010) Objective: To determine the fate of recombinant cry1A(b) and epsps genes from MON 810 maize and 40-3-2 soybean meal in the digestive tract of Ross 308 broilers. The possibility of the transfer of transgenic DNA from feed to chicken tissues was also evaluated.
Experimental design: Experimental maize-soybean meal diets (isonitrogenous and isoenergetic) were fed for 42 days to four replicates (pens) of 40 birds (20 males/20 females) per treatment group. Four treatment groups included (1) control: isogenic, parental non-GM maize and non-GM soybean meal, (2) non-GM maize and GM soybean meal, (3) GM maize and non-GM soybean meal and (4) GM maize and GM soybean meal. At the 43 day of age, the broilers were slaughtered. DNA was extracted from gut content and tissues and was analyzed for the presence of transgenic fragments using the PCR method, allowing detection of 0.1% genetically modified DNA in total DNA isolated from samples.
The transgenic sequences from single-copy genes of soybean (172 bp) and maize (170 bp) were detected only in content of crop and gizzards of broilers consuming feed containing genetically modified maize/soybean. There were no traces of transgenic DNA in duodenum, jejunum, ileum, and caecum digesta, excreta, and in blood, liver, spleen, and breast muscle. Similarly, no small fragments from other single copy genes of soybean and maize (recombinant 35s promoter and NOS terminator, and endogenous lectin and invertase genes) were detected in broiler tissues.
The obtained data indicated that transgenic DNA sequences from MON 810 maize and 40-3-2 soybean are well digested in the gastrointestinal tract and are not transferred to broiler tissues.
Animal health
Observed parameter
DNA fate in digestive tract/tissue
